Stay updated with breaking news from Handok Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biocon Limited partners with Handok Inc. for exclusive licensing of Synthetic Liraglutide in South Korea, targeting weight management market.
Major Histocompatibility Complex Class I negative tumors are refractory to immune-oncology therapies, including resistance to checkpoint blockers, due to the loss of the fundamental recognition of...
A leading Eastern European contract research organization, successfully completed the recruitment of 236 subjects in a Phase III osteoarthritis...
04/20/22 Clinical Leader Newsletter
Non–Muscle-Invasive Bladder Cancer (NMIBC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 20